The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery
Stopped early
Conditions studied: Atrial Fibrillation
In brief
The purpose of the investigators study is to investigate the correlation between naturally occurring chemicals, called reactive oxygen species (ROS), in the blood of human patients and the development of an abnormal heart rhythm, known as atrial fibrillation (AF). The development of atrial fibrillation is associated with increased medical problems like stroke. Many factors seem to cause the development of AF, and this rhythm occurs frequently after open heart surgery. When patients develop AF after cardiac surgery they are at increased risk for cognitive changes, infections, the development of kidney failure, and increased length of hospitalization. ROS are chemicals in blood and tissues that tend to cause microscopic blood vessel and heart damage. These chemicals occur naturally as the result of chemical reactions that occur in states of stress and inflammation, like tissue trauma and as the result of smoking. Patients who undergo cardiac surgery may have higher levels of ROS because of their underlying medical conditions. In addition, the organized tissue trauma that occurs in the setting of surgery may serve to increase ROS levels further. In turn, the higher ROS levels may put patients at even higher risk for the development of AF. The investigators believe that increased levels of ROS may help potentiate a patient's development of AF. Accordingly the investigators aim to measure ROS levels before and after surgery to see if there are particular levels that predict the development of this abnormal heart rhythm. By developing a better knowledge of the relationship between ROS and AF, the investigators hope to better understand another possible method of detecting patients who are at the highest risk of developing AF before it occurs after surgery. If these patients are better identified, this may eventually lead to medical treatment to prevent AF; and hopefully this will result in a decrease of the malicious effects that result from developing this abnormal heart rhythm.
Key facts
- Study ID
- NCT00846534
- Run by
- University of Illinois at Chicago
- People needed
- 100
- Starts
- 2008-04-01
- Expected to finish
- 2013-04-01
- Last updated by the study team
- 2014-04-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years
- Sinus rhythm at the time of enrollment as documented by ECG, telemetry, or Holter monitoring
- Scheduled for an open heart surgery
- Able to provide informed consent
You may not qualify if…
- Systemic inflammatory diseases (e.g., collagen vascular diseases, infections)
- Malignant neoplasms
- Hyperthyroidism
- Uncontrolled hypertension (blood pressure > 180/100 at rest) on medications
- An illness that might result in death within 1 year
- Implanted devices for designed for active management of atrial arrhythmias by pacing or defibrillation
- Current illicit drug use
- Current ethanol abuse
- Presence of paroxysmal, persistent, or permanent atrial fibrillation at the time of enrollment
Where it is running
- University of Illinois at Chicago — Chicago, Illinois, United States
- Advocate Christ Medical Center — Oak Lawn, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.